Busque também em nossas outras coleções:

Tipo de arquivo:

Categorias:

Orientação:

Tipo da licença:

Total de Resultados: 130

Página 1 de 2

F044/1550 Semaglutide diabetes medication, illustration
RF
F044/1549 Weight loss drug, conceptual illustration
RF
C066/7973 Overweight person taking weight loss drug, illustration
DC
F046/3935 Weight loss drug, conceptual illustration
RF
F046/3494 Weight loss drug, conceptual illustration
RF
F046/3496 Weight loss drug, conceptual illustration
RF
F046/2740 GLP-1 analogue pill, conceptual illustration
RF
F046/2741 GLP-1 analogue medication, composite image
RF
F046/2739 Semaglutide medication, illustration
RF
F040/2940 GLP-1 receptors and semaglutide agonists, illustration
RF
F045/7195 Weight loss drug, conceptual illustration
RF
F040/2938 GLP-1 receptor activated by semaglutide, illustration
RF
F040/2939 Inactivated GLP-1 receptor near semaglutide, illustration
RF
F045/9091 Insulin, illustration
RF
F045/9092 Insulin, illustration
RF
F045/9093 Insulin, illustration
RF
F045/9094 Insulin in the blood, illustration
RF
F045/9095 Insulin in the blood, illustration
RF
F045/9096 Insulin, illustration
RF
F045/7756 Young woman with type 2 diabetes, illustration
RF
F045/7760 Type 2 diabetes and insulin resistance, illustration
RF
F045/7759 Glucose and insulin in type 1 diabetes, illustration
RF
F045/7867 Insulin and glucose in type 1 diabetes, illustration
RF
F045/7868 Insulin deficiency in type 1 diabetes, illustration
RF
F045/7869 Type 1 diabetes, illustration
RF
F045/7772 Islets of Langerhans in diabetes, illustration
RF
F045/7783 Islets of Langerhans in diabetes, illustration
RF
F045/7739 Diabetic neuropathy in the legs, illustration
RF
F045/7782 Pancreas and the islets of Langerhans in diabetes, illustration
RF
F045/7768 Artery with high glucose levels, illustration
RF
F045/7866 Insulin and blood glucose control, illustration
RF
C062/3245 Insulin detemir, molecular model
DC
C062/3246 Insulin detemir, molecular model
DC
F040/5092 GLP-1 receptors and semaglutide agonists, illustration
RF
F045/6533 Tirzepatide molecule, conceptual illustration
RF
F045/6534 Tirzepatide molecule, conceptual illustration
RF
F045/6543 Tirzepatide molecule, conceptual illustration
RF
F045/6548 Tirzepatide molecule, conceptual illustration
RF
F045/6549 Tirzepatide molecule, conceptual illustration
RF
F045/6552 Tirzepatide molecule, conceptual illustration
RF
F045/6532 Tirzepatide molecule, conceptual illustration
RF
F045/6540 Tirzepatide molecule, conceptual illustration
RF
F045/6541 Tirzepatide molecule, conceptual illustration
RF
F045/6542 Tirzepatide molecule, conceptual illustration
RF
F045/6544 Tirzepatide molecule, conceptual illustration
RF
F045/6545 Tirzepatide molecule, conceptual illustration
RF
F045/6546 Tirzepatide molecule, conceptual illustration
RF
F045/6547 Tirzepatide molecule, conceptual illustration
RF
F045/6550 Tirzepatide molecule, conceptual illustration
RF
F045/6551 Tirzepatide molecule, conceptual illustration
RF
F045/6553 Tirzepatide molecule, conceptual illustration
RF
F045/6554 Tirzepatide molecule, conceptual illustration
RF
F043/8472 Semaglutide diabetes medication, illustration
RF
F033/1535 Diabetes type 2 and healthy glucose metabolism, illustration
RF
F044/7665 Tirzepatide antidiabetic drug bound to receptor, illustration
RF
F044/7683 Tirzepatide antidiabetic drug and receptord, illustration
RF
F043/9065 Semaglutide diabetes medication, illustration
RF
F043/9066 Semaglutide diabetes medication, illustration
RF
F043/9067 Semaglutide diabetes medication, illustration
RF
F043/9068 Semaglutide diabetes medication, illustration
RF
F043/9069 Semaglutide diabetes medication, illustration
RF
F043/9070 Semaglutide diabetes medication, illustration
RF
F043/9071 Semaglutide diabetes medication, illustration
RF
F043/9072 Semaglutide diabetes medication, illustration
RF
F043/9073 Semaglutide diabetes medication, illustration
RF
C060/9567 Semaglutide diabetes medication, illustration
DC
C060/9568 Semaglutide diabetes medication, illustration
DC
C060/9569 Semaglutide diabetes medication, illustration
DC
C060/9570 Semaglutide diabetes medication, illustration
DC
C060/9571 Semaglutide diabetes medication, illustration
DC
C060/9572 Semaglutide diabetes medication, illustration
DC
C060/9573 Semaglutide diabetes medication, illustration
DC
C060/9574 Semaglutide diabetes medication, illustration
DC
C060/9575 Semaglutide diabetes medication, illustration
DC
F043/9074 Semaglutide weight loss drug, conceptual illustration
RF
F043/9075 Semaglutide weight loss drug, conceptual illustration
RF
F043/9076 Semaglutide weight loss drug, conceptual illustration
RF
F043/9077 Semaglutide weight loss drug, conceptual illustration
RF
F043/9078 Semaglutide weight loss drug, conceptual illustration
RF
F043/9079 Semaglutide weight loss drug, conceptual illustration
RF
F043/9080 Semaglutide weight loss drug, conceptual illustration
RF
F043/9081 Semaglutide weight loss drug, conceptual illustration
RF
F043/9082 Semaglutide weight loss drug, conceptual illustration
RF
C060/9576 Semaglutide weight loss drug, conceptual illustration
DC
C060/9577 Semaglutide weight loss drug, conceptual illustration
DC
C060/9578 Semaglutide weight loss drug, conceptual illustration
DC
C060/9579 Semaglutide weight loss drug, conceptual illustration
DC
F043/9103 Semaglutide molecule, illustration
RF
F043/9104 Semaglutide molecule, illustration
RF
F043/9105 Semaglutide molecule, illustration
RF
F043/9106 Semaglutide molecule, illustration
RF
F033/1536 Diabetes type 1 and 2, illustration
RF
C059/2709 Tirzepatide antidiabetic drug action, illustration
DC
F036/3498 Activation of NLRP3 inflammasome, illustration
RF
C059/2722 Antidiabetic drug semaglutide molecular structure, illustration
DC
F041/9789 Blood sugar regulation, illustration
RF
F033/1533 Diabetes and healthy glucose metabolism, illustration
RF
F042/7883 Diabetic nephropathy, illustration
RF
F042/7884 Diabetic nephropathy, illustration
RF
F042/7885 Diabetic nephropathy, illustration
RF

Total de Resultados: 130

Página 1 de 2